If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year
06 Sep 2020 9:08 AM
The agreement calls for US to pay Sanofi and GlaxoSmithKline up to $2.1 billion to supply it with enough vaccines for 50 million people
01 Aug 2020 9:51 AM
Sanofi sparked controversy after announcing that US patients would get their vaccine first as US government was helping to fund the vaccine
14 May 2020 4:44 PM
Drug, Libtayo, is used to treat a rare form of skin cancer, in patients whose condition has not improved following surgery or chemotherapy.
29 Sep 2018 12:20 PM
Next-generation vaccines by Japan’s Takeda and the U.S. National Institutes of Health are now in late-stage testing.
29 Jan 2018 3:42 PM